Interventions During Pregnancy May Counteract Genetic Obesity Risk in Offspring, Research Suggests

Interventions During Pregnancy May Counteract Genetic Obesity Risk in Offspring, Research Suggests
0
(0)

Being born heavier than normal adds to a person’s genetic risk for being overweight or becoming obese during adulthood, a study suggests.

The findings indicate that genes interact with the environment in the uterus to determine the likelihood of becoming obese. As such, a person’s genetic predisposition for obesity may be counteracted by monitoring maternal weight and nutrition during pregnancy, the research stated.

The study, “Are genes destiny? Exploring the role of intrauterine environment in moderating genetic influences on body mass,” was published in the American Journal of Human Biology and was conducted by Jinho Kim, PhD, a professor at The Chinese University of Hong Kong.

Obesity is a major and global public health problem, and while different lines of research have looked at genetic and environmental factors separately, little is known about how much these factors interact to contribute to obesity risk.

The study addressed whether the environment may offset genetic effects on body mass. Specifically, it focused on the influence of the prenatal environment on the genetic risk of excess weight in adulthood.

To do that, Kim studied if pairs of siblings carried genetic risk variants in the obesity-associated FTO gene, while also exploring the environment they had been exposed to in their mother’s uterus, as assessed by their weight at birth. Then, these data were compared with body mass index (BMI) after 50 years of age.

Genetic, BMI, and birth weight data were collected from 876 people (corresponding to 438 pairs of siblings) enrolled in the Wisconsin Longitudinal Study. Of note, analyzing siblings enabled better control of family characteristics that could confound the results. Overall, participants had an average BMI of 26.5 kg/m2 and 20% of them were obese (BMI of 30 kg/mor greater).

Results of different models consistently revealed that the association between carrying an obesity risk variant in FTO and having a high BMI is predominantly found among individuals heavier at birth. This means that being born with a higher weight adds to one’s genetic risk for being obese later in life.

One explanation for this environmental effect in utero on obesity, called the fetal origins of obesity hypothesis, suggests that maternal obesity and maternal overeating increase the risk of obesity and type 2 diabetes in the offspring. This may happen through biological programming, a process in which cells and organs are altered to compensate for an oversupply of energy, fat, and sugar during critical periods of development.

“Genes are not destiny and environmental factors may offset the effects of obesity‐promoting genes,” Kim wrote.

The findings suggest that genetic risks for obesity can be counteracted with interventions during pregnancy.

“Monitoring birth weight may help reduce the risk of overweight/obesity later in life by directly addressing the programming effects of the in utero environment and indirectly moderating the obesity-promoting genetic effects,” Kim added.

He also wrote that initiatives to monitor and reduce excessive maternal weight during pregnancy, and to optimize gestational weight gain may be helpful.

Ana is a molecular biologist with a passion for communication and discovery. As a science writer, her goal is to provide readers, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
Total Posts: 9
José is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimer’s disease.
×
Ana is a molecular biologist with a passion for communication and discovery. As a science writer, her goal is to provide readers, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
Latest Posts
  • cholesterol and mutations
  • TBX15
  • BMI
  • childhood obesity in Mexico

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?